Backbench Business Committee

13 October 2026

Committee Actual start House of Commons

17:02 - 17:43
Speaker 1
Order, order.  Welcome to the meeting of the Backbench Business Committee where we will be considering applications from colleagues for debates in the main chamber and in Westminster Hall on a Tuesday morning and a Thursday afternoon. 

The first application we have is from Scott Arthur on the future of cancer research in the UK.  And I declare my interest as being a strong supporter of Cancer Research UK, chair of the All-Party Group on pancreatic cancer.  Scott, do you want to present your case?  This is, oh sorry, I should say, this is for a request for a debate in the chamber. 
17:43 - 18:43
Speaker 2
Yeah, and thank you, Chair.  And I'm sure, I mean, all of us have interest in this area, so you won't be alone in having, you've got a formal conflict of interest, I'm sure we've all got an interest in this subject.  So this is about looking at how we can progress faster and further cancer research in the UK.  So fundamentally, it's about holding the government to account, but also thinking about not just the health benefits of work in this area, but also the economic benefits. 

So the UK is a world lead, has a world leading record in cancer research and breakthroughs have transformed prevention, diagnosis and treatment of cancers in my lifetime.  You know, I have to say I'm in my 50s actually.  But there is a feeling that perhaps whilst progress was faster in the past, it's starting to slow a little.  So we have the cancer plan, which was published earlier this year, but we've had a few changes in personnel I think in that department since then.  So this is a chance just really to keep them on their toes, although we are this is not DHSC, it is a chance to expose some light on the progress that has been made. 

The rest of the transcript is for Pro customers

Unlock the full transcript, chat, and every analysis feature with Polyfact Pro.

Ask anything about this video — I analyse its transcript to answer.